BRIDGEBIO PHARMA: LAUNCH OF SECONDARY PUBLIC OFFERING OF 5 MLN SHARES OF COMMON STOCK BY SELLING STOCKHOLDER KKR GENETIC DISORDER L.P

Reuters · 1d ago

Please log in to view news